
Tango Therapeutics Inc (NASDAQ:TNGX)’s 12-Month Price Target Is Now Set At 18.
In last trading session, Tango Therapeutics Inc (NASDAQ:TNGX) saw 0.83 million shares changing hands with its beta currently measuring 0.89. Company’s recent per share price